Archives

by in
Entry Author Date Location
SeaGen’s Big Day at the FDA, Hutch Nabs $20M HIV Grant, Allozyne’s Nasdaq Plan, & More Seattle-Area Life Sciences News 07/14/11 Seattle
Fate Therapeutics Trims Chemistry Staff, Bets on Biotech Drugs 07/07/11 National
iPierian Shakeup Continues, as Chairman Corey Goodman, Scientist Doug Melton Exit Stem Cell Startup 06/15/11 San Francisco
Termeer Joins Verastem Board 06/13/11 Boston
At The Great Lakes Stem Cell (Innovation) Center, Researchers Anxiously Wait For Technology To Take Off 06/08/11 Detroit
Will Biotech Ever Again Captivate the Public Imagination, Like Facebook or LinkedIn? 05/16/11 National
iPierian, Stem Cell Startup With Big Science & Big Bucks, Axes Group of Top Executives 05/13/11 San Francisco
Takeda Bets on Fate Therapeutics 05/10/11 San Diego
Geron Nabs $25M Loan from Stem Cell Agency, Paves Way for State Support of Clinical Trials 05/05/11 San Francisco
StemCells Cuts 30% of Staff 05/04/11 San Francisco
Q&A: UCSF’s Jeff Bluestone on the Tricky Balancing Act Between Academia and Industry 03/10/11 San Francisco
Fate CEO Exits for New Co 02/22/11 San Diego
Flagship VentureLabs, Creating and Spinning Out Cleantech and Life Sciences Startups for 10 Years, Takes the Veil Off 02/17/11 Boston
Fluidigm Completes IPO on 2nd Try, Geron CEO Exits, Amgen Pushes ‘Son of Dmab,’ & More Bay Area Life Sciences News 02/11/11 San Francisco
Fluidigm Raises $75M in Second Chance at IPO 02/10/11 San Francisco
Geron CEO Steps Down 02/09/11 San Francisco
Axonia Seeks to Regenerate Nerves a New Way, Sidestepping Stem Cell Controversy 01/25/11 Detroit
Follica Co-Founder and Team Find New Clues About Male Baldness 01/04/11 Boston
John Mendlein, Biotech Exec With Surfer Look, Follows Winding Path as “Parallel Entrepreneur” 01/03/11 San Diego
Fluidigm, Maker of Genomic Tools, Takes Second Crack at IPO, Hoping for Less Drama 12/14/10 San Francisco
Aastrom Announces $22.5M Public Offering to Help Fund Stem Cell Trials 12/10/10 Detroit
How to Raise Money for an Honest-to-God Innovative Biotech Startup: Highlights from Convergence 12/06/10 National
Aastrom Maps Out Pivotal Trial Strategy With Adult Stem Cell Therapy 10/22/10 Detroit
Exelixis Gets $60M from Bristol, Genentech Surpasses Original Herceptin, Synosia Pockets $30M, & More Bay Area Life Sciences News 10/15/10 San Francisco
Fate Therapeutics Snags Deal With Becton Dickinson to Market Stem Cell Technology 10/14/10 San Diego
Onyx Delays FDA Push, Vega Aims High Against Diabetes, Stanford Biologist Goes Open Source, & More Bay Area Life Sciences News 10/08/10 San Francisco
Sage Attracts Bigwigs, Hutch Adds Immunotherapy Center, the Pro-Life Vaccine Firm, & More Seattle-Area Life Sciences News 10/07/10 Seattle
ModeRNA, Stealth Startup Backed By Flagship, Unveils New Way to Make Stem Cells 10/04/10 Boston
Embryonic Stem Cell Research Foe, Tracy Deisher, Seeks to Market Pro-Life Vaccines 10/01/10 Seattle
Will the Stem Cell Ruling Affect Venture Capital Investing? 09/01/10 San Francisco
Page 2 of 6 « previous page · next page »

Xconomy Events Across the Network

The Napa Summit 2013: New Rules for Growth

San Francisco · 6/3/13

More Xconomy Events

Xconomy’s Most Popular

  1. Henri Termeer on Startups, Drug Prices, Getting Older (Part 1)
  2. Xconomy Opens in Texas, Expanding Roundup of Innovation Across U.S.
  3. Life After PowerPoint: Prezi Zooms Ahead in Digital Storytelling
  4. Do You Need an Extended Warranty? Do the Math, Says SquareTrade
  5. Announcing Xconomy Napa Summit 2013: New Rules for Growth

Xconomy on Demand

Did you miss something? Don't despair…

Xconomy offers a number of ways to subscribe for free!

Subscribe Now
IDG Tech Network
Protected by Mozy
Eventbrite - events made easy

Business, life sciences, and technology news — covering Boston, Seattle, San Diego, Detroit, San Francisco, New York, Boulder/Denver, Texas and beyond.

© 2007-2013, Xconomy, Inc. Xconomy is a registered service mark of Xconomy, Inc. All rights reserved.

Website development support from Andrew Koyfman with design support from Rob Hunter.